Thermo Fisher to sell Cole-Palmer to GTCR for $480M in cash Thermo Fisher Scientific has signed a definitive agreement to sell its Cole-Parmer channel business to private equity firm GTCR, LLC for $480M in cash. Thermo Fisher anticipates closing the transaction in Q3, subject to customary closing conditions and applicable regulatory approvals. The company expects an immaterial impact to 2014 adjusted EPS and will update annual guidance in its Q2 earnings release on July 23.
Thermo Fisher added to US 1 List at BofA/Merrill As previously reported, BofA/Merrill added Thermo Fisher to the US 1 List. Thermo Fisher is the firm's top pick in the tools sector due to organic revenue growth being driven by improving end-markets, capital deployment opportunities, and relative valuation. Shares are Buy rated with a $151 price target.
Cowen to hold a conference 35th Annual Health Care Conference is being held in Boston on March 2-4 with webcasted company presentations to begin on March 3 at 8 am; not all company presentations may be webcasted. Webcast Link